Role of NFKB2 on the early myeloid differentiation of CD34+ hematopoietic stem/progenitor cells

Differentiation

Volumn 80, Issue 4-5, 2010, Pages 195-203

  De Molfetta, Greice Andreotti ^a   Lucíola Zanette, Dalila ^a   Alexandre Panepucci, Rodrigo ^a   dos Santos, Anemarie Ramos Dinarte ^a   da Silva, Wilson Araújo ^a   Antonio Zago, Marco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone marrow; Hematopoietic stem progenitor cells; Myeloid differentiation; NFKB2; SiRNA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA B2; PROTEIN NFKB1; PROTEIN NFKB2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION;

ADULT; ANTIGENS, CD34; BONE MARROW; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; MYELOID CELLS; NF-KAPPA B P52 SUBUNIT; RNA, SMALL INTERFERING; STEM CELLS;

EID: 78049260464     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.07.004     Document Type: Article

References (48)

1. Burt R.K. Clinical utility in maximizing CD34+ cell count in stem cell grafts. Stem Cells 1999, 17:373-376.
2. Beinke S., Ley S.C. Functions of NF-kB1 and NF-kB2 in immune cell biology. Biochem. J. 2004, 382:393-409.
3. Borer R.A., Lehner C.F., Eppenberger H.M., et al. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390.
4. Bonizzi G., Karim M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
5. Cans C., Passer B.J., Shalak V., et al. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. PNAS 2003, 100:13892-13897.
6. DiGiusto D., Chen S., Combs J., et al. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994, 84:421-432.
7. Dutta J., Fan Y., Gupta N., Fan G., et al. Current insights into the regulation of programmed cell death by NF-kB. Oncogene 2006, 25:6800-6816.
8. Dejardim E. The alternative NF-kappaB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochem. Pharmacol. 2006, 72:1161-1179.
9. Ferrari F., Bortoluzzi S., Coppe A., et al. Genomic expression during human myelopoiesis. BMC Genomics 2007, 8:264-283.
10. Gao Z., Fackler M.J., Leung W., et al. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- preparations. Exp. Hematol. 2001, 29:910-921.
11. Gavrilin M.A., Deucher M.F., Boeckman F., et al. Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. Biochem. Biophys. Res. Commun. 2000, 277:37-42.
12. Grumont R.J., Rourke I.J., O'Reilly L.A., et al. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 1998, 187:663-674.
13. Gommerman J.L., Browing J.L. Lymphotoxin/LIGHT lymphoid microenvironments and autoimmune disease. Nat. Immunol. Rev. 2003, 3:642-655.
14. Giuliani M, Giron-Michel J, Negrini S, et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS One 2008, 3(5):e2241.
15. Hauer J., Schener S.P., Ramakrishman P., et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kB pathway by TRAF-binding TNFRs. PNAS 2005, 102:2874-2879.
16. Huddelston C.A., Weinberg A.D., Parker D.C. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells. Eur. J. Immunol. 2006, 36:1093-1103.
17. Hacker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, R13(357):1-19.
18. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34: structure, biology and clinical utility. Blood 1996, 87:1-13.
19. Komor M., Güller S., Baldus C.D., et al. Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation. Stem Cells 2005, 23:1154-1169.
20. Kim Y.C., Wu Q, Chen J, et al. The transcriptome of human CD34+ hematopoietic stem-progenitor cells. PNAS 2009, 106:8278-8283.
21. Kucharczak J., Simmons M.J., Fan Y., et al. To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003, 22:8961-8982.
22. Karin M., Cao Y., Greten F.R., et al. Nf-kB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2:301-310.
23. Keats J.J., Fonseca R., Chesi M., et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007, 12:131-144.
24. Liu X-L., Yuan J-Y., Zhang J-W., Wang R-X. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J. Leukocyte Biol. 2007, 82:986-1002.
25. Li J., Zhang X., Sejas D.P., et al. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leukocyte Res. 2005, 29:1415-1423.
26. Liptay S., Schimid R.M., Nabel E.G., et al. Transcriptional regulation of NF-kB2: evidence for kB-mediated positive and negative autoregulation. Mol. Cell. Biol. 1994, 14:7695-7703.
27. Lian R.H., Kumar V. Murine natural killer cell progenitors and their requirements for development. Semin. Immunol. 2002, 14:453-460.
28. Mao M., Fu G., Wu J-S., et al. Identification of genes expressed in human CD34+ hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. PNAS 1998, 95:8175-8180.
29. Mayani H., Lansdorp P.M. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998, 16:153-165.
30. Martin T., Cardarelli P.M, Parry G.C., et al. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur. J. Immunol. 1997, 27:1091-1097.
31. Nakata S., Matsumura I., Tanaka H., et al. NF-κB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J. Biol. Chem. 2004, 279:55578-55586.
32. Phillips R.L., Ernst R.E., Brunk B., et al. The genetic program of hematopoietic stem cells. Science 2000, 288:1635-1640.
33. Panepucci R.A., Calado R.T., Rocha V., et al. Higher expression of transcription targets and components of the NF-{kappa}B pathway is a distinctive features of umbilical cord blood CD34+ precursors. Stem Cells 2007, 25:189-196.
34. Pyatt D.W., Stillman W.S., Yang Y., et al. An essential role for the NF-kB in human CD34+ bone marrow cell survival. Blood 1999, 93:3302-3308.
35. Ruijter J.M., Van Kampen A.H., Baas F. Statistical evaluation of SAGE libraries: consequences for experimental design. Physiol. Genomics 2002, 11:37-44.
36. Reid S., Ritchie A., Boring L., et al. Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood 1999, 93:1524-1533.
37. Sutherland D.R., Stewart A.K., Keating A. CD34 antigen: molecular features and potential clinical applications. Stem Cells 1993, 3:50-57.
38. Silva I.T., Vĉncio R.Z.N., Oliveira T.Y.K., et al. ProbFAST: Probabilistic functional analysis system tool. BMC Bioinf. 2010, 11:161-169.
39. Speirs K., Lieberman L., Caamano J., et al. Cutting edge: NF-κB2 is negative regulator of dendritic cell function. J. Immunol. 2003, 171:752-756.
40. Song J., Salek-Ardakani S., Rogers P.R., et al. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 2004, 5:150-158.
41. So T., Croft M. Cutting edge: OX40 inhibits TGF-B and antigen-driven conversion of naÏve CD4 T cells into CD25+Foxp3+ T cells. J. Immunol. 2007, 179:1427-1430.
42. Solt L.A., Madge L.A., Orange J.S., et al. Interleukin-1-induced NF-κB activation in NEMO-dependent but does not require IKKΒ. J. Biol. Chem. 2007, 282:8724-8733.
43. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004, 18:1176-1199.
44. The Gene Ontology Consortium Gene Ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25-29.
45. Van Epps D.E., Bender J., Lee W., et al. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Blood Cells 1994, 20:411-423.
46. Wu F., Chakravarti S. Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kB inhibition in a mouse model of chronic colitis. J. Immunol. 2007, 179:6988-7000.
47. Zanetti M., Castiglioni P., Schoenberger S., et al. The role of relB is essential for regulating the adaptive immune response. Am. NY Acad. Sci. 2003, 978:249-257.
48. Zhang M.Y., Sun S.C., Bell L., et al. NF-kappaB transcription factors are involved in normal erythropoiesis. Blood 1998, 91:4136-4144.